Ocular Surgery News U.S. Edition Current Issue

The following articles appeared in the print edition of Ocular Surgery News U.S. Edition.

Table of Contents

• Descemet’s membrane endothelial keratoplasty slowly on the rise
• Alimera Sciences reports $6.7 million quarterly net loss
• Eleven Biotherapeutics reports $6.1 million loss in first quarter
• Eylea sales up in first quarter
• Glaukos posts $0.9 million in first-quarter income
• Imprimis reports $5 million net loss in first quarter
• Industry struggling to meet WHO goal for avoidable visual impairment
• In-office pattern electroretinogram efficient for glaucoma diagnosis
• Inotek reports $10.7 million first-quarter net loss
• Iridex reports $10.5 million in quarterly revenue
• Johnson & Johnson CEO discusses future of health care
• Neurotech’s macular telangiectasia treatment sees positive phase 2 results
• Novartis’ RTH258 for wet AMD meets endpoints in phase 3 trials
• Ocular Therapeutix reports $16 million quarterly loss
• Omeros reports $15.1 million quarterly net loss
• Ophthotech reports $43.1 million net loss in first quarter
• Second Sight reports $7.5 million first-quarter loss
• Spark Therapeutics posts first-quarter net loss of $52.3 million
• Speaker: Vision care should continue to be essential health care
• Sustained-release therapies remove patient factor from glaucoma treatment
• Uveitis can complicate cataract surgery and limit vision gains
• Finding balance in ophthalmology Uday Devgan, MD
• Ophthalmologists explore scientific and personal aspects of near-death experience John C. Hagan III, MD, FACS, FAAO; Jean R. Hausheer, MD, FACS
• Man presents with blurry vision, flashes, floaters and redness Deborah Witkin, MD; Andre J. Witkin, MD
• Fine needle aspiration biopsy safe in uveal melanoma
• Teleretinal diabetic retinopathy screening program decreases need for referrals
• Two iStent injects and topical travoprost reduce IOP, medication use through 18 months
• Air quality in different surgery centers
• Substantial changes likely in eye banking, corneal transplantation community Richard L. Lindstrom, MD
• VIDEO: Data analytics important for private ophthalmology practices
• VIDEO: Physicians can benefit from big data
• VIDEO: Premium channel, co-management hot topics at OCTANe Ophthalmology Technology Summit
• VIDEO: Private equity to have 'significant impact' on ophthalmology
• How much of an opportunity is quarter-DMEK for eye banks?
• The state of dry eye care, part 2 Darrell E. White, MD